These authors contributed equally to this work.
CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer
Article first published online: 28 NOV 2013
© 2013 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Volume 105, Issue 1, pages 26–34, January 2014
How to Cite
Cancer Sci 105 (2014) 26–34
- Issue published online: 24 JAN 2014
- Article first published online: 28 NOV 2013
- Accepted manuscript online: 16 OCT 2013 09:49AM EST
- Manuscript Accepted: 10 OCT 2013
- Manuscript Revised: 4 OCT 2013
- Manuscript Received: 13 JUN 2013
- National Key Technology R&D Program. Grant Number: 2011ZX09307-001-05
- National Natural Science Foundation of China. Grant Number: (30972780)
This article has been cited by:
- 1CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma, Tumor Biology, 2015, 36, 10, 7849, , , , , , , , ,
- 2CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells, Clinical and Translational Oncology, 2015, 17, 8, 632, , , , , , , ,
- 3CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma, Journal of Experimental & Clinical Cancer Research, 2015, 34, 1, , , , , , , , ,
- 5CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest, Scientific Reports, 2014, 4, 6812, , , , , , , , , , , ,